ClinicalTrials.Veeva

Menu

Postpartum Hemorrhage: Incidence and Risk Factors

C

CHU Brugmann University Hospital

Status

Completed

Conditions

Postpartum Hemorrhage

Treatments

Procedure: Pregnant women who have given birth vaginally or by cesarean section

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Postpartum hemorrhage(PPH) is a major cause of maternal morbidity and mortality across the world. Incidence of PPH varies in the literature from 2 to 10%, most recent studies find around 10% of PPH and 2% of severe PPH.

In this study, the incidence of PPH in the maternal ward of the CHU Brugmann will be analyzed. This is a tertiary maternal ward with a high proportion of high risk pregnancies with around 3000 admissions per year.

Primary aim of this study is to evaluate the epidemiology of PPH in the CHU Brugmann, incidence and possible underlying causes will be identified and compared to the current literature. A data mining technique will be used to construct a prediction model for PPH.

Enrollment

2,402 patients

Sex

Female

Ages

18 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Pregnant women who have given birth vaginally or by cesarean section at the CHU Brugmann between January 1, 2020 and August 31, 2022
  • ≥ 18 years

Exclusion criteria

  • Age ≤ 18 years
  • Age > 60 years
  • delivery before 25th week of pregnancy
  • delivery outside of the hospital
  • abortion

Trial contacts and locations

1

Loading...

Central trial contact

Denis Schmartz, MD; Rihana Bel-Adel

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems